Milrinone — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

2 Countries

Phase III

Phase II

Phase III: 2 Phase II: 1

Indications tested

3 total

Cerebral hemodynamic optimization by milrinone for the prevention of delayed cerebral ischemia in severe subarachnoid hemorrhage Recruiting

2024-513410-35-00 Phase III 1 country Centre Hospitalier Universitaire De Toulouse
Beta receptor modulation trial in cardiogenic shock patients supported by V-A ECMO Recruiting

2024-511805-42-00 Phase II 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
MIVAR - Milrinone Infusion for VAsospam treatment in subarachnoid hemoRrhage Ended

2024-515994-83-00 Phase III 1 country Centre Hospitalier Universitaire D'Angers

Showing 1–3 of 3 trials